BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 17498558)

  • 21. A fourth case of 8p11 myeloproliferative disorder transforming to B-lineage acute lymphoblastic leukaemia. A case report.
    JabbarAl-Obaidi M; Rymes N; White P; Pomfret M; Smith H; Starczynski J; Johnson R
    Acta Haematol; 2002; 107(2):98-100. PubMed ID: 11919390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of hypereosinophilic syndromes of myeloproliferative expression with the combination of hydroxyurea and interferon alpha. Apropos of 7 cases].
    Coutant G; Blétry O; Prin L; Hauteville D; de Puyfontaine O; Abgrall JF; Godeau P
    Ann Med Interne (Paris); 1993; 144(4):243-50. PubMed ID: 8368716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute lymphoblastic leukemia.
    Onciu M
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):655-74. PubMed ID: 19577163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Janus kinase 2 mutations in Philadelphia negative chronic myeloproliferative disorders: clinical implications.
    Panani AD
    Cancer Lett; 2009 Oct; 284(1):7-14. PubMed ID: 19269737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A der(1;15)(q10;q10) is a rare nonrandom whole-arm translocation in patients with acute lymphoblastic leukemia.
    Park TS; Song J; Lee KA; Lee SG; Yoon S; Kim JS; Lyu CJ; Choi JR
    Cancer Genet Cytogenet; 2007 Dec; 179(2):132-5. PubMed ID: 18036400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic pathways in acute leukemias: a proposal for a multimodal approach.
    Haferlach T; Bacher U; Kern W; Schnittger S; Haferlach C
    Ann Hematol; 2007 May; 86(5):311-27. PubMed ID: 17375301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous extramedullary hemopoiesis in chronic myeloproliferative and myelodysplastic disorders.
    Haniffa MA; Wilkins BS; Blasdale C; Simpson NB
    J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S28-31. PubMed ID: 16843120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Some new findings in the pathogenesis of myeloproliferative disorders and new insight into more effective treatment].
    Klener P
    Cas Lek Cesk; 2006; 145(1):4-8. PubMed ID: 16468234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxycarbamide: a user's guide for chronic myeloproliferative disorders.
    Spivak JL; Hasselbalch H
    Expert Rev Anticancer Ther; 2011 Mar; 11(3):403-14. PubMed ID: 21417854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precursor T-lymphoblastic leukemia with an inv(6)(p21.2q27).
    Wong KF; Leung JN
    Cancer Genet Cytogenet; 2005 Apr; 158(2):192-3. PubMed ID: 15796969
    [No Abstract]   [Full Text] [Related]  

  • 31. Circulating progenitor cells in chronic myeloproliferative diseases.
    Rosti V; Massa M
    Haematologica; 2006 Nov; 91(11):1445-7. PubMed ID: 17082003
    [No Abstract]   [Full Text] [Related]  

  • 32. Introduction: overview of chronic myeloproliferative disorders.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):1-2. PubMed ID: 9930549
    [No Abstract]   [Full Text] [Related]  

  • 33. [Myeloproliferative states].
    Chrobák L
    Vnitr Lek; 1980 Feb; 26(2):107-5. PubMed ID: 6987807
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of chronic myeloproliferative syndrome followed by precursor T-cell acute lymphoblastic leukemia.
    Bacher U; Haferlach T; Kern W; Harich HD; Schnittger S; Haferlach C
    Cancer Genet Cytogenet; 2007 May; 175(1):52-6. PubMed ID: 17498558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Histopathology and molecular pathology of chronic myeloproliferative disorders].
    Kreipe HH
    Veroff Pathol; 1993; 141():1-158. PubMed ID: 8372486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of the literature.
    Mertens F; Johansson B; Heim S; Kristoffersson U; Mitelman F
    Leukemia; 1991 Mar; 5(3):214-20. PubMed ID: 2013980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inv(1)(p22q25) in chronic myeloproliferative disease: constitutional or clonal defect?
    Wong KF; Wong WC; Cheuk W
    Cancer Genet Cytogenet; 2005 Apr; 158(2):188-91. PubMed ID: 15796968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in biological and therapeutic aspects of myeloproliferative disorders.
    Mancini M; Diverio D; Alimena G; Mandelli F
    Curr Opin Hematol; 1994 Jul; 1(4):261-7. PubMed ID: 9371292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.